Pharmacognosy Magazine

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 17  |  Issue : 6  |  Page : 196--204

Naringin, a natural flavonone glycoside attenuates N-nitrosodiethylamine- induced hepatocellular carcinoma in sprague-dawley rats


Reetuparna Acharya1, Namita Mishra1, Abhishek Kumar1, Pritha Bose1, Ashok Pattnaik1, Kunal Mukhopadhyay2, Priyashree Sunita3, Shakti Prasad Pattanayak4 
1 Department of Pharmaceutical Sciences and Technology, Division of Pharmacology, Birla Institute of Technology, Ranchi, Jharkhand, India
2 Department of Biotechnology, Birla Institute of Technology, Ranchi, Jharkhand, India
3 Department of Health, Family Welfare and Medical Education, Government Pharmacy Institute, Government of Jharkhand, Ranchi, Jharkhand, India
4 Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Government of India, Gaya, Bihar, India

Correspondence Address:
Shakti Prasad Pattanayak
Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Government of India, Fatehpur, Gaya - 824 236, Bihar
India

Background: Hepatocellular Carcinoma (HCC) being proclaimed as the world's fifth common cancer shows a high mortality rate due to delayed diagnosis. Regular day-to-day activities expose us to promotive factors that potentiate further to risk of liver damage, cirrhosis, and carcinogenesis. Matrix metalloproteinases (MMPs), a proteolytic enzyme, involved in cancer invasion are considered as a prognostic biomarker for HCC. Naringin (NAR), a flavanone glycoside, is recognized to have therapeutic efficacy in HCC. Objectives: The present research work focuses on evaluation of chemotherapeutic efficiency, NAR against HCC in Sprague–Dawley rats. Materials and Methods: In vitro studies were primarily carried out to estimate the cell viability of NAR in HepG2 cells followed by further justifications through in vivo studies in N-nitrosodiethylamine developed HCC. The efficacy of NAR at doses 30mg/kg/day and 60mg/kg/day was assessed through estimation of liver marker enzymes, antioxidant levels, glycoproteins, and level of MMP-2 and 9 to confirm the hypothesis. Results: While in vitro results revealed pronounced potency of NAR in inhibiting HepG2 cell viability, NAR concurrently stabilized the serum levels of liver marker enzymes, antioxidant levels, and serum glycoproteins. It also significantly reduced the levels of MMPs in treatment groups which was confirmed by zymography. Conclusion: With the support of these results, it can be concluded that NAR attenuates HCC by controlling the alterations in morphological, biochemical, and histopathological parameters that make it a suitable candidate as a potential chemotherapeutic agent against HCC.


How to cite this article:
Acharya R, Mishra N, Kumar A, Bose P, Pattnaik A, Mukhopadhyay K, Sunita P, Pattanayak SP. Naringin, a natural flavonone glycoside attenuates N-nitrosodiethylamine- induced hepatocellular carcinoma in sprague-dawley rats.Phcog Mag 2021;17:196-204


How to cite this URL:
Acharya R, Mishra N, Kumar A, Bose P, Pattnaik A, Mukhopadhyay K, Sunita P, Pattanayak SP. Naringin, a natural flavonone glycoside attenuates N-nitrosodiethylamine- induced hepatocellular carcinoma in sprague-dawley rats. Phcog Mag [serial online] 2021 [cited 2022 May 27 ];17:196-204
Available from: http://www.phcog.com/article.asp?issn=0973-1296;year=2021;volume=17;issue=6;spage=196;epage=204;aulast=Acharya;type=0